Midaia (Mida Rheuma App) addresses a genuine medical need for patients with inflammatory rheumatic diseases, backed by a legitimate operational footprint (approx. 30 employees). However, the submission suffers critically from exaggerated and unverifiable claims (e.g., audience reach of 'everyone' and traction cited as 'most people have used my product'), which contradict the niche nature of a medical prescription app. While the 30-person team suggests better underlying fundamentals than the score reflects, the evaluation methodology heavily penalizes the lack of credible evidence and low-quality response data provided.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline